Drugs by condition
Drugs approved for dry eye disease
Last checked: Nov 19, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations
Brand-name drugs approved
7
Still marketed, NDA or BLA
Drug classes
5
Novel drugs
4
New molecular entities and new biologics
In development
13
Investigational drugs in Phase 2 or 3
Newest approvals
The most recently first-approved brand-name drugs for dry eye disease.
All approved drugs for dry eye disease, by class
Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 1 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.
Calcineurin Inhibitor Immunosuppressant (2)
TRPM8 Thermoreceptor Agonist (1)
- Tryptyr Acoltremon · Alcon Labs INC · 2025
Semifluorinated Alkane (1)
- Miebo Perfluorohexyloctane · Bausch and Lomb INC · 2023
Lymphocyte Function-Associated Antigen-1 Antagonist (1)
- Xiidra Lifitegrast · Bausch and Lomb INC · 2016
Class not listed in FDA's data (2)
Drugs in development for dry eye disease
Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.
- DFL24498Phase 32 trials
Dompé Farmaceutici S.p.A · Dry Eye Disease (DED), Atopic Keratoconjunctivitis
- ABBV-444Phase 31 trial
AbbVie · Dry Eye Disease
- CAM-101Elate Ocular, FD hPLPhase 31 trial
Cambium Bio Limited · Dry Eye Disease, Dry Eye, Dry Eyes Chronic
- licaminlimabPhase 31 trial
Oculis · Dry Eye Disease (DED)
- SJP-0132Phase 31 trial
Senju Pharmaceutical Science & Technology (Beijing) Co., Ltd. · Dry Eye
- VVN001Phase 31 trial
VivaVision Biotech, Inc · Dry Eye
- 0.25% RCI001RCI001Phase 22 trials
ORA, Inc. · Dry Eye Disease (DED), Dry Eye
- BL1107Phase 22 trials
Bausch & Lomb Incorporated · Dry Eye Disease, Glaucoma
- TTAX03Phase 22 trials
BioTissue Holdings, Inc · Knee Osteoarthritis, Knee Pain Chronic, Knee Arthritis
- BRM421Phase 21 trial
BRIM Biotechnology Inc. · Dry Eye Disease (DED), Keratoconjunctivitis Sicca
- BTV100Phase 21 trial
BioTheraVision, Inc. · Dry Eye
- TJO-087Phase 21 trial
Taejoon Pharmaceutical Co., Ltd. · Dry Eye Syndrome (DES)
- VSJ-110Phase 21 trial
Vanda Pharmaceuticals · Dry Eye
More on dry eye disease: recruiting trials · published research
Related in ophthalmology: Wet macular degeneration · Diabetic macular edema · Glaucoma · Geographic atrophy
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.